Alzheimer's Disease Clinical Trials in Washington

18 recruiting studies across 1 city

Browse by City

All Trials in Washington

Phase

Trial	Phase	Sponsor	Dist.
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)	Phase 3	Bristol-Myers Squibb	<1 mi
Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia	—	Fred Hutchinson Cancer Center	<1 mi
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation	Phase 2/3	Washington University School of Medicine	<1 mi
Indian Transforming Alzheimer's Care Training (INTACT)	N/A	Washington State University	<1 mi
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers	N/A	University of Washington	<1 mi
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation	Phase 2/3	Washington University School of Medicine	<1 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)	Phase 3	Bristol-Myers Squibb	<1 mi
Promoting Physical Activity in Older Hispanic/Latino(a) Adults	N/A	Kaiser Permanente	<1 mi
Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain	N/A	University of Washington	<1 mi
Late Onset Alzheimer's Disease	—	Columbia University	<1 mi
Dominantly Inherited Alzheimer Network (DIAN)	—	Washington University School of Medicine	<1 mi
A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors	N/A	University of Washington	<1 mi
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)	Phase 2	Merck Sharp & Dohme LLC	6 mi
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)	Phase 3	Karuna Therapeutics	6 mi
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease	Phase 2	Intra-Cellular Therapies, Inc.	6 mi
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease	Phase 2	Lighthouse Pharmaceuticals, Inc.	6 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)	Phase 3	Bristol-Myers Squibb	8 mi
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)	Phase 3	Bristol-Myers Squibb	10 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.